Skip to main content
. 2006 Jul 27;174(9):982–989. doi: 10.1164/rccm.200603-344OC

TABLE 5.

FINAL DIAGNOSIS OF ALL CASES ACCORDING TO ENB OR OTHER DIAGNOSTIC TECHNIQUE

Obtained Diagnosis Number Success (%)
By ENB Malignant disease (n = 32) NSCLC 26
 Adenocarcinoma 12
 Squamous cell Ca 7
 NSCLC-unspecified 4
 Large cell carcinoma 3 45 (80.3%)
Small cell lung Ca 4
Other malignant condition 2
Benign disease (n = 8) Sarcoidosis 3
Pneumonia 2
Aspergilloma 2
Histoplasmoma 1
Other benign conditions* (n = 5) 5
By other technique Malignant disease (n = 11) Adenocarcinoma§ 6 11 (19.6%)
NSCLC-unspecified 4
Other malignant condition 1
Total cases 56 (100)

Definition of abbreviations: Ca = cancer; ENB = electromagnetic navigation bronchoscopy; NSCLC = non–small cell lung carcinoma.

*

Regression or not changing of the lesion by CT follow-up (n = 2) in 5 and 3 mo of follow-up, respectively; stable lesion (n = 1) in 2-mo period confirmed as hamartoma based on CT and nonspecific pathology; stable lesion (n = 1) in 4-mo period looked like granulomatous disease, surveillance CTs were planned by 6 mo; stable lesion (n = 1) in 3-mo period in a patient with HIV/AIDS, Mycobacterium avium intracellulare grew in his sputum culture.

Hepatocellular Ca (n = 1), metastatic adenocarcinoma (n = 1).

ENB reached the target lymph nodes, diagnosis was also supported by bronchoalveolar lavage in two cases, granulomatous tissue from lymph node compatible with sarcoidosis obtained in one case.

§

By thoracotomy (n = 4), CT-fine needle asp (n = 1), mediastinoscopy (n = 1).

By CT-fine needle asp (n = 2), thoracotomy (n = 1), positron-emission tomography scan follow-up (n = 1).

B cell lymphoma by thoracotomy (n = 1).